ZA869347B - Inhibition of the 5-lipoxygenase pathway - Google Patents

Inhibition of the 5-lipoxygenase pathway

Info

Publication number
ZA869347B
ZA869347B ZA869347A ZA869347A ZA869347B ZA 869347 B ZA869347 B ZA 869347B ZA 869347 A ZA869347 A ZA 869347A ZA 869347 A ZA869347 A ZA 869347A ZA 869347 B ZA869347 B ZA 869347B
Authority
ZA
South Africa
Prior art keywords
inhibition
lipoxygenase pathway
lipoxygenase
pathway
Prior art date
Application number
ZA869347A
Other languages
English (en)
Inventor
Paul Elliot Bender
John Gerald Gleason
Nabil Hanna
Don Edgar Griswold
Ivan Lantos
Kazys Arunas Razgaitis
Henry Martin Sarau
Susan Cathy Shilcrat
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA869347B publication Critical patent/ZA869347B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA869347A 1985-12-12 1986-12-11 Inhibition of the 5-lipoxygenase pathway ZA869347B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80840785A 1985-12-12 1985-12-12

Publications (1)

Publication Number Publication Date
ZA869347B true ZA869347B (en) 1987-11-25

Family

ID=25198674

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA869347A ZA869347B (en) 1985-12-12 1986-12-11 Inhibition of the 5-lipoxygenase pathway

Country Status (5)

Country Link
US (1) US4719218A (ko)
JP (1) JPS62153286A (ko)
KR (1) KR870006053A (ko)
CA (1) CA1296005C (ko)
ZA (1) ZA869347B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US5665752A (en) * 1988-07-26 1997-09-09 Sankyo Company, Limited Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
US5354768A (en) * 1988-07-26 1994-10-11 Sankyo Company, Limited Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
KR920702621A (ko) * 1989-06-13 1992-10-06 스튜어트 알. 슈터 단핵세포 및/또는 마크로파지에 의한 인터루킨-1 또는 종양회사인자 생성의 억제
JPH06504779A (ja) * 1990-12-13 1994-06-02 スミスクライン・ビーチャム・コーポレイション 新規ｃｓａｉｄｓ
DE10004157A1 (de) 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
GB0108770D0 (en) * 2001-04-06 2001-05-30 Eisai London Res Lab Ltd Inhibitors
CN1518550A (zh) * 2001-06-21 2004-08-04 ʷ��˿�������ȳ�ķ���޹�˾ 用于预防和治疗疱疹病毒感染的咪唑并[1,2-a]吡啶衍生物
EP1432712B1 (en) 2001-10-05 2006-05-17 SmithKline Beecham Corporation Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
US7534800B2 (en) * 2002-03-28 2009-05-19 Eisai R & D Development Co., Ltd. 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
PA8595001A1 (es) * 2003-03-04 2004-09-28 Pfizer Prod Inc Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
GB0305142D0 (en) * 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
EP1628975A2 (en) 2003-05-16 2006-03-01 Eisai Co., Ltd. Jnk inhibitors
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
GB0516156D0 (en) * 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
JP4759104B2 (ja) * 2005-08-26 2011-08-31 株式会社ユネクス センサ保持装置
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
PL2731949T3 (pl) 2011-07-13 2018-10-31 Tiumbio Co., Ltd. 2-pirydylo podstawione imidazole jako inhibitory alk5 i/lub alk4

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL164285C (nl) * 1968-01-09 1980-12-15 Rhone Poulenc Sa Werkwijze ter bereiding van een farmaceutisch preparaat, dat een imidazoÿ2.1-bÿthiazoolderivaat bevat, de gevormde farmaceutische preparaten, alsmede werkwijze voor het bereiden van dit imidazoÿ2.1-bÿthiazoolderivaat.
ZA725841B (en) * 1971-09-30 1973-05-30 Ici Ltd Anti-bacterial process
GB1541321A (en) * 1976-03-10 1979-02-28 Metabio 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation
US4064260A (en) * 1976-07-29 1977-12-20 E. I. Du Pont De Nemours And Company Anti-inflammatory diarylimidazothiazoles and their corresponding S-oxides
US4263311A (en) * 1976-09-27 1981-04-21 Smithkline Corporation 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
US4153706A (en) * 1978-02-13 1979-05-08 Smithkline Corporation 6-Hydroxy-5,6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
GB2039882A (en) * 1979-01-05 1980-08-20 Ciba Geigy Ag Bicyclic thiadiaza compounds and their use as medicaments
US4186205A (en) * 1979-01-08 1980-01-29 Smithkline Corporation 2,3-Di(4-substituted phenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazoles
US4507481A (en) * 1983-07-29 1985-03-26 Pennwalt Corporation Pyrrolo[1,2-a]imidazoles and imidazo[1,2-a]pyridines
US4578387A (en) * 1984-03-05 1986-03-25 Eli Lilly And Company Inotropic agents

Also Published As

Publication number Publication date
US4719218A (en) 1988-01-12
CA1296005C (en) 1992-02-18
KR870006053A (ko) 1987-07-09
JPS62153286A (ja) 1987-07-08

Similar Documents

Publication Publication Date Title
GB8609999D0 (en) Installations
GB8600362D0 (en) Drain fitting
ZA869347B (en) Inhibition of the 5-lipoxygenase pathway
GB8506352D0 (en) Corrosion inhibition
GB8605820D0 (en) Corrosion inhibition
GB8529270D0 (en) Flange plug
PH22299A (en) Aromatic compounds of the spartein series
PT83903B (en) Inhibition of the 5-lipoxygenase pathway
GB8625208D0 (en) Corrosion inhibition
GB8527884D0 (en) Sanitary arrangement
GB8600221D0 (en) Drain fitting
GB8521566D0 (en) Decontamination shower
ZA869348B (en) Inhibition of the 5-lipoxygenase pathway
GB8511623D0 (en) Heteroanalogs of imidazobenzodiazepines
GB8529206D0 (en) Wall member
GB8506982D0 (en) Shower unit
ZA869349B (en) Inhibition of the 5-lipoxygenase pathway
ZA863425B (en) 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
GB8616030D0 (en) Fitting
IE863239L (en) Inhibition of the 5-lipoxygenase pathway.
GB8520895D0 (en) Corrosion inhibition
CA54195S (en) Lavatory
CA54197S (en) Lavatory
CA54198S (en) Lavatory
CA54199S (en) Lavatory